Recruitment

Recruitment Status
Completed
Estimated Enrollment
55

Inclusion Criterias

Male or female Caucasians aged between 18 and 60 years
Skin type I - IV according to Fitzpatrick
Acute symptom of pruritus at Baseline
...
Male or female Caucasians aged between 18 and 60 years
Skin type I - IV according to Fitzpatrick
Acute symptom of pruritus at Baseline
Patients with mild to moderate AD (Atopic Dermatitis) presenting a scoring AD (SCORAD) rating below 50
Acute AD symptoms on each assessment areas (local SCORAD ≥ 3 and </= 12) at Baseline

Exclusion Criterias

Any other skin disease at the test area that would interfere the clinical assessment in the opinion of the investigator
Moles, tattoos, strong pigmentation, or scars at the test area that would interfere the clinical assessment
UV-therapy or the use of solarium within 30 days before screening as well as during the trial
...
Any other skin disease at the test area that would interfere the clinical assessment in the opinion of the investigator
Moles, tattoos, strong pigmentation, or scars at the test area that would interfere the clinical assessment
UV-therapy or the use of solarium within 30 days before screening as well as during the trial
Regular intake of antiphlogistic drugs (for example, nonsteroidal anti-inflammatory drug [NSAIDs])
Any alternative treatment of AD (e.g. acupuncture, kinesiology, and homoeopathy) within 30 days before screening as well as during the trial
Any condition or treatment which might influence the trial (e.g. any treatment with topical antibiotics, antifungals, or corticoids) within 14 days prior to screening as well as during the trial (exception: topical treatment of AD lesions other than the test areas (for example, face) with low potency steroids restricted to small areas)

Summary

Conditions
Dermatitis, Atopic
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Single (Investigator)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 60 years
Gender
Both males and females

Inclusion Criterias

Male or female Caucasians aged between 18 and 60 years
Skin type I - IV according to Fitzpatrick
Acute symptom of pruritus at Baseline
...
Male or female Caucasians aged between 18 and 60 years
Skin type I - IV according to Fitzpatrick
Acute symptom of pruritus at Baseline
Patients with mild to moderate AD (Atopic Dermatitis) presenting a scoring AD (SCORAD) rating below 50
Acute AD symptoms on each assessment areas (local SCORAD ≥ 3 and </= 12) at Baseline

Exclusion Criterias

Any other skin disease at the test area that would interfere the clinical assessment in the opinion of the investigator
Moles, tattoos, strong pigmentation, or scars at the test area that would interfere the clinical assessment
UV-therapy or the use of solarium within 30 days before screening as well as during the trial
...
Any other skin disease at the test area that would interfere the clinical assessment in the opinion of the investigator
Moles, tattoos, strong pigmentation, or scars at the test area that would interfere the clinical assessment
UV-therapy or the use of solarium within 30 days before screening as well as during the trial
Regular intake of antiphlogistic drugs (for example, nonsteroidal anti-inflammatory drug [NSAIDs])
Any alternative treatment of AD (e.g. acupuncture, kinesiology, and homoeopathy) within 30 days before screening as well as during the trial
Any condition or treatment which might influence the trial (e.g. any treatment with topical antibiotics, antifungals, or corticoids) within 14 days prior to screening as well as during the trial (exception: topical treatment of AD lesions other than the test areas (for example, face) with low potency steroids restricted to small areas)

Locations

Münster, Nordrhein-Westfalen, 48155
Münster, Nordrhein-Westfalen, 48155

Tracking Information

NCT #
NCT01948869
Collaborators
Not Provided
Investigators
Study Director: Bayer Study Director Bayer